Literature DB >> 4745542

The clinical course of idiopathic membranous nephropathy.

D T Erwin, J V Donadio, K E Holley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4745542

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  15 in total

Review 1.  Medical decision-making in membranous nephropathy: how to use limited clinical research evidence in patient management.

Authors:  Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

2.  Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).

Authors:  G Mohácsi; A Magori; S Sonkodi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 3.  Therapy of idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini
Journal:  Springer Semin Immunopathol       Date:  1987

4.  Clinical significance of glomerular C3 deposition in primary membranous nephropathy.

Authors:  Halil Yazici; Yasar Caliskan; Ozgur Akin Oto; Erol Demir; Safak Mirioglu; Ahmet Burak Dirim; Yasemin Ozluk; Egemen Cebeci; Taner Basturk; Ali Riza Ucar; Lala Soltanova; Kanan Nuriyev; Isin Kilicaslan
Journal:  J Nephrol       Date:  2021-01-02       Impact factor: 3.902

5.  The natural history of the non-nephrotic membranous nephropathy patient.

Authors:  Michelle A Hladunewich; Stephan Troyanov; Jennifer Calafati; Daniel C Cattran
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-06       Impact factor: 8.237

6.  Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy.

Authors:  Aliza Thompson; Daniel C Cattran; Melanie Blank; Patrick H Nachman
Journal:  J Am Soc Nephrol       Date:  2015-06-15       Impact factor: 10.121

7.  Membranous Nephropathy: Quantifying Remission Duration on Outcome.

Authors:  Daniel C Cattran; Esther D Kim; Heather Reich; Michelle Hladunewich; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 10.121

8.  Membranous nephropathy: high-dose alternate-day therapy with prednisone.

Authors:  J Hopper; C G Biava; W H Tu
Journal:  West J Med       Date:  1981-07

9.  Nature of the glomerular capillary injury in human membranous glomerulopathy.

Authors:  O Shemesh; J C Ross; W M Deen; G W Grant; B D Myers
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

10.  Factors contributing to the outcome in 100 adult patients with idiopathic membranous glomerulonephritis.

Authors:  T Tóth; S Takebayashi
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.